Q1 2020 Holdings
Filed 2020-05-15 | 62 holdings | $291.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc | COM | 98985W102 | $887 | 25,000 | 0.0% |
| Bellerophon Therapeutics Inc(BLPHUSD) | COM | 078771300 | $1.1K | 98,809 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $1.2K | 920,000 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $2.0K | 1,102,194 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.6K | 2,450,543 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.0K | 2,000,000 | 0.0% |
| Lifesci Acquisition Corp | UNIT 03/31/2025 | 53228P208 | $3.0K | 300,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.1K | 764,252 | 0.0% |
| Barclays BK PLC | SHRT TRM ETN 48 | 06746P621 | $3.5K | 75,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $3.7K | 1,531,872 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $3.7K | 890,700 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $4.3K | 175,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $4.4K | 317,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.5K | 290,577 | 0.0% |
| Artara Therapeutics Inc(PRTOUSD) | COM | 04300J107 | $4.6K | 199,567 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $4.7K | 2,913,091 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.8K | 600,000 | 0.0% |
| Matinas Biopharma Hldgs Inc | COM | 576810105 | $6.9K | 11,478,634 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $7.2K | 150,000 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $7.9K | 3,284,072 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.0K | 725,782 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $8.4K | 844,789 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $8.8K | 416,495 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $9.0K | 2,250,000 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $9.7K | 4,800,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $9.8K | 4,000,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $10.2K | 300,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $11.5K | 1,009,255 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $12.8K | 250,000 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $13.7K | 1,123,105 | 0.0% |
| Barclays BK PLCPut | PUT | 06746P951 | $13.9K | 300,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $16.5K | 4,075,000 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $17.3K | 2,383,673 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460E539 | $17.6K | 1,250,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $17.7K | 1,775,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.4K | 1,300,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $20.5K | 1,466,051 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $21.5K | 2,325,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $22.2K | 2,185,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $26.0K | 6,205,882 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $27.6K | 7,034,598 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $28.7K | 1,733,583 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $29.7K | 1,883,315 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $30.0K | 675,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $30.7K | 975,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $36.3K | 765,400 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $44.0K | 1,532,510 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $46.2K | 400,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $56.0K | 2,075,905 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $65.9K | 135,000 | 0.0% |